Profile
Emma Giegerich is a Director, Applied Epidemiology, in the Deerfield Institute and joined the Firm in 2018.
Prior to Deerfield, Ms. Giegerich worked as an Epidemiologist at Bristol-Myers Squibb, where she supported the Strategic Planning & Forecasting team in formulation of financial and market forecasts and creation of business strategy.
Previously, Ms. Giegerich worked as a Research Associate at WG.
Ms. Giegerich holds an M.P.H.
in Epidemiology from New York University and dual B.A. degrees from Colgate University in Molecular Biology and Peace and Conflict Studies
Emma Giegerich active positions
| Companies | Position | Start |
|---|---|---|
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Director/Board Member | 01/02/2018 |
Training of Emma Giegerich
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Colgate University
Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Finance |
- Stock Market
- Insiders
- Emma Giegerich
















